1. Lister BJ, Poland M, DeLapp RE. Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. Am J Med. 1993;95(suppl 2A):2S-9S.
2. Relafen (nabumetone) tablets. In: Physicians’ Desk Reference, 49th edn. Medical Economics Data Production Co., Montvale, NJ 1995:2395-7.
3. Blower PR. The unique pharmacologic profile of nabumetone. J Rheumatol. 1992;19(suppl 36):13–9.
4. Brett MA, Buscher G, Ellrich E et al. Lack of enterohepatic circulation of the active metabolite of nabumetone in humans. J Rheumatol. 1992;19(suppl 36):81–2.
5. Laneuville O, Breuer DK, DeWitt DL, Hla T, Funk CD, Smith WL. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol ExpTher. 1994;271:927–34.